It never ceases to amaze me how researchers are still making breakthroughs with AIMS, a method we published 10 years ago with @hallettmiket.bsky.social . Now, AIMS is proving instrumental in revealing BC subtype switching before and after neoadjuvant treatment. https://tinyurl.com/bdday25t